First-quarter flagship product sales are in increasing trend

The domestic major pharmaceutical firms saw overall sales growth in the first six-month of this year, fueled by brisk sales of their flagship products.

Market experts said the trend has been mainly attributed to reinforced marketing activities of major pharmaceutical firms in an attempt to lure customers back to their renowned brands and jump-start the stall sales.

However, sales ...